Autoimmune limbic encephalitis
ORPHA:623615DiseaseAll ages
Фенотипы (HPO)24
Частый (30–79%)19
HP:0000708Atypical behavior
HP:0000709Psychosis
HP:0000716Depression
HP:0000737Irritability
HP:0000739Anxiety
HP:0001250Seizure
HP:0001254Lethargy
HP:0001268Mental deterioration
HP:0001945Fever
HP:0002315Headache
HP:0002922Increased CSF protein concentration
HP:0010843EEG with focal slow activity
HP:0012229CSF pleocytosis
HP:0012658Abnormal brain FDG positron emission tomography
HP:0033687Short term memory impairment
HP:5000016Anti-Hu antibody positivity
HP:5000020Anti-LGI1 antibody
HP:6000397CSF oligoclonal immunoglobulin G bands
HP:6001115EEG with temporal slowing
Периодический (5–29%)3
HP:0010532Paroxysmal vertigo
HP:5000005Anti-CASPR2
HP:5000010Anti-GABA(B)R antibody
Исключён (0%)2
HP:0002383Infectious encephalitis
HP:0100836Malignant neoplasm of the central nervous system
Эпидемиология2
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Point prevalence | 1-9 / 100 000 | 1.7 | Europe | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.25 | Europe | Value and class |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)